Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
18 studies found for:    Vasculitis | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Vasculitis | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Conditions: Autoimmune Disease;   Vascular Disease
Intervention:
2 Not yet recruiting A Randomized Multicenter Study for Isolated Skin Vasculitis
Conditions: Primary Cutaneous Vasculitis;   Cutaneous Polyarteritis Nodosa;   IgA Vasculitis;   Henoch-Schönlein Purpura
Interventions: Drug: Colchicine;   Drug: Dapsone;   Drug: Azathioprine
3 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
4 Recruiting VCRC Tissue Repository
Conditions: Aortitis;   Cutaneous Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis;   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Henoch-Schonlein Purpura;   IgA Vasculitis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu Arteritis;   Churg-Strauss Syndrome
Intervention:
5 Recruiting Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis
Condition: Takayasu Arteritis
Intervention:
6 Recruiting Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
Condition: Takayasu's Arteritis
Intervention:
7 Recruiting Determining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Conditions: Eosinophilic Granulomatosis With Polyangiitis;   Churg-Strauss Syndrome
Intervention:
8 Recruiting Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Wegener's
Intervention:
9 Recruiting Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
Conditions: Healthy Volunteers;   Abnormal Phagocyte Function
Intervention:
10 Recruiting The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Conditions: Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Vasculitis
Interventions: Drug: 5 mg prednisone;   Drug: 0 mg prednisone
11 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
12 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
13 Recruiting PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Conditions: Cardiac Disease;   Dementia;   Inflammatory Disease;   Fever of Unknown Origin;   Vasculitis;   Osteomyelitis;   FDG Avid Cancers
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
14 Recruiting The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Condition: Granulomatosis With Polyangiitis
Interventions: Drug: Prednisone 5 mg/day;   Drug: Prednisone 0 mg/day
15 Recruiting Immunogenetic Mechanisms in Behcet's Disease
Conditions: Behcet's Disease;   Uveitis
Intervention:
16 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
17 Recruiting Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Conditions: Autoimmune Disease;   Crohn Disease;   Inflammatory Disorder;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Takayasu Arteritis
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 Clofarabine;   Procedure: Positron Emission Tomography
18 Recruiting Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
Condition: Polyarteritis Nodosa
Intervention:

Study has passed its completion date and status has not been verified in more than two years.